Projects per year
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Center for Advanced Antibody Drug Development, Organization for Promotion of Research is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
RSウイルス-細菌の共感染と重症下気道炎の連関解析
Kawahara, E. (Principal Investigator)
Japan Society for the Promotion of Science
2024/07/31 → 2026/03/31
Project: Research Project
-
口腔細菌由来プロテアーゼからのCOVID-19病態解明～新規重症化制御法への展開
Morinaga, Y. (Principal Investigator), 谷英樹 (Co-Investigator(Kenkyū-buntansha)), Kawasuji, H. (Co-Investigator(Kenkyū-buntansha)), Asmaa, B. A. A. (Co-Investigator(Kenkyū-buntansha)), Kawahara, E. (Co-Investigator(Kenkyū-buntansha)) & Yamada, H. (Co-Investigator(Kenkyū-buntansha))
Japan Society for the Promotion of Science
2023/04/01 → 2026/03/31
Project: Research Project
Research output
- 42 Citations
- 4 h-index
- 8 Article
-
Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions
Kawai, A., Shimizu, T., Tanaka, H., Shichinohe, S., Anindita, J., Hirose, M., Kawahara, E., Senpuku, K., Shimooka, M., Quynh Mai, L. T., Suzuki, R., Nogimori, T., Yamamoto, T., Hirai, T., Kato, T., Watanabe, T., Akita, H. & Yoshioka, Y., 2025/02/05, In: Molecular Therapy. 33, 2, p. 529-547 19 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles
Omata, D., Kawahara, E., Munakata, L., Tanaka, H., Akita, H., Yoshioka, Y. & Suzuki, R., 2024/11/04, In: Molecular Pharmaceutics. 21, 11, p. 5672-5680 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction
Kawahara, E., Senpuku, K., Kawaguchi, Y., Yamamoto, S., Yasuda, K., Kuroda, E., Ouji-Sageshima, N., Ito, T., Hirai, T., Shibata, T. & Yoshioka, Y., 2024/12, In: npj Vaccines. 9, 1, 187.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations